Small Business Resources, Business Advice and Forms from AllBusiness.com

Western pharmaceutical companies face loss of more drug patents.

Byline: Tracey Boles

Aug. 29--The multi-national pharmaceutical companies GlaxoSmithKline and Pfizer have recently paid the price for taking a casual approach to drug patents in China in the early 1990s. Their nonchalance has allowed Chinese drug makers to manufacture cheap generic copies of best-selling drugs out to launch patent challenges.

More are sure to follow now precedents have been set. Lawyers are poring over patents filed before Chinese patent law came into effect on 1 January 1993; the lawyer who masterminded cases against Glaxo and Pfizer on beh

In addition, make sure to read these premium articles also available with your free trial:

T T T
art_print Printart_email Email 16x16-digg-guy  Digg It delicious-small  del.icio.us

Related Resources

Free AllBusiness Articles

  • Pfizer vs. The Philippines.
    • MANILA -- The debate over high drug prices recently hit the spotlight once again as a U.S.-based pharmaceutical giant sought to stop the Philippine government's plans to import a cheaper version of a hypertension medicine. Pfizer in March filed suit in local court against the Philippine International Trading Corporation (PITC) ......
  • Patents vs. people.
    • INTENSE PRESSURE BY U.S. TRADE NEGOTIATORS and multinational drug companies on Argentina to adopt wider-reaching intellectual property laws may succeed in eradicating the Argentine system of providing relatively cheap pharmaceuticals to its citizens. Argentine drug companies competitively manufacture and sell a wide variety of drugs that are controlled as legal ......
  • Deloitte & Touche report on Canada's chemical sector.
    • A recent report from Deloite Touche Tohmatsu International, states that the Canadian chemical industry is experiencing a revival, encouraged by the relatively stable Canadian dollar, a growing economy and increasing export opportunities. Indeed, the chemical industry in the wider North American region is coming out of a six year slowdown....
  • Implications of the trips agreement for developing countries: Pharmaceutical patent laws in Brazil and South Africa in the 21st century
    • NOTE I. INTRODUCTION On January 1, 1995 the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs) became effective as part of the Uruguay Round of the General Agreement on Tariffs and Trade (GATT).1 Compliance with the TRIPs Agreement requires member countries of the World Trade Organization (WTO) to establish ......
  • The evergreen patent system: pharmaceutical company tactics to extend patent protections. (Patently Abusive).
    • BRAND-NAME DRUG COMPANIES SELL more than $130 billion worth of pharmaceuticals in the U.S. marker every year. The high revenue steam is due in part to new drugs to treat new ailments, and an aging population that is living longer and taking more medications than previous generations. But the foundation ......
  • U.S. drug trafficking in South America.
    • Drug lords personify South America in North American media, which pay scant attention to a group of North American drug traffickers collectively known as pharmaceutical companies. Like the illegal drug lords, these multinationals carve out turf that yields fabulous profits at a heavy cost to public health. One reason that ......
  • Chemical Firms Respond To Global Trends
    • Like all other business sectors, the chemical industry is attempting to change with a global economy. Companies are restructuring, merging with one another or entering into joint ventures in an effort to secure new technology platforms, optimize portfolios and enhance returns to create shareholder value. In doing so, many companies ......

Video

Blogs

  • China Strikes Again with Contaminated Blood Thinner
    • In today's global economy, American manufacturers can take the high ground on quality. But will there be a market?
  • A Policy That Exiles Common Sense
    • A Policy That Exiles Common Sense "Where would the U.S. be without the bright, industrious immigrants? If Washington doesn't change its immigration laws, we may soon find out. "Do you mind if we stop at my university?" Dr. Wen-Bin Yan, our vice-president of research, asked me, a hint of ......
  • Can U.S. Manufacturing Companies Compete in the Global Economy? Yes!
    • Manufactured goods from so-called low-wage countries (LWCs) have a 17 percent landed cost advantage over goods manufactured in the U.S - but U.S. companies can still win.
  • Japan: Easier and Faster
    • An agreement between the U.S. Departments of State and Transportation and the government of Japan will slacken the U.S.-Japan bilateral air services agreement and thereby allow increased freedom for U.S. and Japanese airlines.
  • All Bloggers
Related Topics
Tools

Sponsored Links

Site Map | Contact Us | FAQs | About Us | Media Kit | Reprints | RSS Directory | Sign Up for Free Newsletters | Disclosure Policy

Copyright © 1999 - 2008 AllBusiness.com, Inc. All rights reserved.
No part of this content or the data or information included therein may be reproduced,
republished or redistributed without the prior written consent of AllBusiness.com.
Use of this site is governed by our Copyright and Intellectual Property Policy, Terms of Use Agreement and Privacy Policy.

Get In-Depth Company Information from Hoover's | Buy a D&B Credit Report | What is in Your Company's D&B Credit Report? | Article Archives
Online Business Database | Online Business Information | Email Marketing Lists | Sales and Marketing Solutions | Business Mailing Lists
Information and opinions on AllBusiness.com solely represent the thoughts and opinions of the authors and are not endorsed by, or reflect the beliefs of,
AllBusiness.com, its parent company D&B, and its affiliates.